Breaking News

You are here » Indian-Commodity  :  Commodities  :  Jeera  :  Jeera futures edge higher on NCDEX


Jeera futures edge higher on NCDEX

Jeera futures edged higher on NCDEX on expectation of pickup in demand in the physical market. Further, tight stocks position following lower supply from the producing belts too fuelled the uptrend.

The contract for September delivery was trading at Rs 18260.00, up by 1.25% or Rs 225.00 from its previous closing of Rs 18035.00.The open interest of the contract stood at 10614 lots.

The contract for October delivery was trading at Rs 18375.00, up by 1.10% or Rs 200.00 from its previous closing of Rs 18175.00. The open interest of the contract stood at 12684 lots on NCDEX.

Related News

View all news

Jeera futures trade lower on profit booking

Jeera futures traded lower on NCDEX, due to profit booking by participants after the prices peaked counting on improving physical domestic and exports demands from China and Bangladesh. Moreover, anticipation......

Jeera futures trade higher on firm demand

Jeera futures traded higher on NCDEX, due to scanty rainfall in producing centres of Gujarat and Rajasthan, which might impact cumin production this year. Moreover, firm spot demand from domestic......

Jeera futures trade up on NCDEX

Jeera futures traded up on NCDEX, due to concerns on impact of overall output amid water shortage in producing centres of Gujarat and Rajasthan. Besides, pick-up in demand from domestic and exports markets......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......